{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:15:43Z","timestamp":1781540143536,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00393-019-0611-1","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T14:04:15Z","timestamp":1552917855000},"page":"228-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lungenbeteiligung bei rheumatoider Arthritis","Pulmonary involvement in rheumatoid arthritis"],"prefix":"10.1007","volume":"78","author":[{"given":"A.","family":"Krause","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rubbert-Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"611_CR1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1055\/s-0036-1580689","volume":"37","author":"IJ Aparicio","year":"2016","unstructured":"Aparicio IJ, Lee JS (2016) Connective tissue disease-associated interstitial lung diseases: unresolved issues. Semin Respir Crit Care Med 37:468\u2013476","journal-title":"Semin Respir Crit Care Med"},{"key":"611_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nrrheum.2014.115","volume":"10","author":"AI Catrina","year":"2014","unstructured":"Catrina AI, Ytterberg J, Reynisdottir G et\u00a0al (2014) Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis. Nat Rev Rheumatol 10:645\u2013653","journal-title":"Nat Rev Rheumatol"},{"key":"611_CR3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3899\/jrheum.150674","volume":"43","author":"R Conway","year":"2016","unstructured":"Conway R, Low C, Coughlan RJ et\u00a0al (2016) Leflunomide use and risk of lung disease in rheumatoid arthritis: a\u00a0systematic literature review and metaanalysis of randomized controlled trials. J\u00a0Rheumatol 43:855\u2013860","journal-title":"J Rheumatol"},{"key":"611_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/art.38322","volume":"66","author":"R Conway","year":"2014","unstructured":"Conway R, Low C, Coughlan RJ et al (2014) Methotrexate and lung disease in rheumatoid arthritis: a\u00a0meta-analysis of randomized controlled trials. Arthritis Rheum 66:803\u2013812","journal-title":"Arthritis Rheum"},{"key":"611_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13075-015-0835-7","volume":"17","author":"JR Curtis","year":"2015","unstructured":"Curtis JR, Sarsour K, Napalkov P et al (2015) Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor \u03b1 agents, a\u00a0retrospective cohort study. Arthritis Res Ther 17:319","journal-title":"Arthritis Res Ther"},{"key":"611_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.berh.2016.04.006","volume":"30","author":"MK Demoruelle","year":"2016","unstructured":"Demoruelle MK, Mittoo S, Solomon JJ (2016) Connective tissue disease-related interstitial lung disease. Best Pract Res Clin Rheumatol 30:39\u201352","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"611_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.semarthrit.2017.12.012","volume":"48","author":"C Fernandez-Diaz","year":"2018","unstructured":"Fernandez-Diaz C, Loricera J, Casta\u00f1eda S et al (2018) Abatacept in patients with rheumatoid arthritis and interstitial lung disease: a national multicenter study of 63 patients. Semin Arthritis Rheum 48:22\u201327","journal-title":"Semin Arthritis Rheum"},{"key":"611_CR8","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3899\/jrheum.121043","volume":"40","author":"A Fischer","year":"2013","unstructured":"Fischer A, Brown KK, Du Bois RM et al (2013) Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J\u00a0Rheumatol 40:640\u2013646","journal-title":"J Rheumatol"},{"key":"611_CR9","doi-asserted-by":"publisher","first-page":"872120","DOI":"10.1155\/2011\/872120","volume":"2011","author":"MJ Hamblin","year":"2011","unstructured":"Hamblin MJ, Horton MR (2011) Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma. Pulm Med 2011:872120. \n                    https:\/\/doi.org\/10.1155\/2011\/872120","journal-title":"Pulm Med"},{"key":"611_CR10","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard C, Hilberg O, Pedersen AB et al (2017) A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis 76:1700\u20131706","journal-title":"Ann Rheum Dis"},{"key":"611_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrrheum.2013.197","volume":"10","author":"M Jani","year":"2014","unstructured":"Jani M, Hirani N, Matteson EL, Dixon WG (2014) The safety of biologic therapies in RA-associated interstitial lung disease. Nat Rev Rheumatol 10:284\u2013294","journal-title":"Nat Rev Rheumatol"},{"key":"611_CR12","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","volume":"379","author":"PA Juge","year":"2018","unstructured":"Juge PA, Lee JS, Ebstein E et\u00a0al (2018) MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N\u00a0Engl J Med 379:2209\u20132219","journal-title":"N Engl J Med"},{"issue":"26","key":"611_CR13","doi-asserted-by":"publisher","first-page":"e4044","DOI":"10.1097\/MD.0000000000004044","volume":"95","author":"LT Keng","year":"2016","unstructured":"Keng LT, Lin MW, Huang HN et\u00a0al (2016) Diffuse alveolar damage in a\u00a0patient with rheumatoid arthritis under prolonged leflunomide treatment: a\u00a0case report and literature review. Medicine 95(26):e4044. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000004044","journal-title":"Medicine"},{"key":"611_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00393-010-0687-0","volume":"70","author":"G Key\u00dfer","year":"2011","unstructured":"Key\u00dfer G (2011) Methotrexate toxicity. Myths and facts. Z\u00a0Rheumatol 70:108\u2013113","journal-title":"Z Rheumatol"},{"key":"611_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-018-0507-5","author":"G Leuschner","year":"2018","unstructured":"Leuschner G, Neurohr C (2018) What rheumatologists can learn from pneumologists. Z\u00a0Rheumatol. \n                    https:\/\/doi.org\/10.1007\/s00393-018-0507-5","journal-title":"Z Rheumatol"},{"key":"611_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-015-0520-x","volume":"17","author":"EB Lugli","year":"2015","unstructured":"Lugli EB, Correia RE, Fischer R et al (2015) Expression of citrulline and homocitrulline residues in the lungs of non-smokers and smokers: implications for autoimmunity in rheumatoid arthritis. Arthritis Res Ther 17:9","journal-title":"Arthritis Res Ther"},{"key":"611_CR17","doi-asserted-by":"publisher","first-page":"h6819","DOI":"10.1136\/bmj.h6819","volume":"352","author":"SC Mathai","year":"2016","unstructured":"Mathai SC, Danoff SK (2016) Management of interstitial lung disease associated with connective tissue disease. BMJ 352:h6819","journal-title":"BMJ"},{"key":"611_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/rheumatology\/kes350","volume":"52","author":"LK Mercer","year":"2013","unstructured":"Mercer LK, Davies R, Galloway JB et al (2013) Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. Rheumatology 52:91\u201398","journal-title":"Rheumatology"},{"key":"611_CR19","doi-asserted-by":"publisher","first-page":"e005615","DOI":"10.1136\/bmjopen-2014-005615","volume":"4","author":"T Nakashita","year":"2014","unstructured":"Nakashita T, Ando K, Kaneko N et\u00a0al (2014) Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis. BMJ Open 4:e5615","journal-title":"BMJ Open"},{"key":"611_CR20","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/acr.21986","volume":"65","author":"C Nannini","year":"2013","unstructured":"Nannini C, Medina-Velasquez YF, Achenbach SJ et al (2013) Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a\u00a0population-based study. Arthritis Care Res 65:1243\u20131250","journal-title":"Arthritis Care Res"},{"key":"611_CR21","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s10067-017-3707-5","volume":"36","author":"J Rojas-Serrano","year":"2017","unstructured":"Rojas-Serrano J, Herrera-Bringas D, P\u00e9rez-Rom\u00e1n DI et al (2017) Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis. Clin Rheumatol 36:1493\u20131500","journal-title":"Clin Rheumatol"},{"key":"611_CR22","first-page":"1318","volume":"55","author":"C Sharp","year":"2016","unstructured":"Sharp C, McCabe M, Dodds N et\u00a0al (2016) Rituximab in autoimmune connective tissue disease associated interstitial lung disease. Baillieres Clin Rheumatol 55:1318\u20131324","journal-title":"Baillieres Clin Rheumatol"},{"issue":"6","key":"611_CR23","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM et\u00a0al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188(6):733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"key":"611_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/BOR.0000000000000270","volume":"28","author":"B Wallace","year":"2016","unstructured":"Wallace B, Vummidi D, Khannaa D (2016) Management of connective tissue diseases associated interstitial lung disease: a\u00a0review of the published literature. Curr Opin Rheumatol 28:236\u2013245","journal-title":"Curr Opin Rheumatol"},{"key":"611_CR25","unstructured":"Xie F, Annapureddy N, Chen L et\u00a0al (2017) Rheumatoid arthritis and the risk for interstitial lung disease: a\u00a0comparison of risk associated with biologic and conventional DMARDs. Arthritis Rheumatol 69(suppl 10). Abstract-Nr. 137. \n                    https:\/\/acrabstracts.org\/abstract\/rheumatoid-arthritis-and-the-risk-for-interstitial-lung-disease-a-comparison-of-risk-associated-with-biologic-and-conventional-dmards\/"},{"key":"611_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10067-017-3561-5","volume":"36","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Li H, Wu N, Dong X, Zheng Y (2017) Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol 36:817\u2013823","journal-title":"Clin Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-019-0611-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-019-0611-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-019-0611-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:22:41Z","timestamp":1584404561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-019-0611-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["611"],"URL":"https:\/\/doi.org\/10.1007\/s00393-019-0611-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"18 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Krause und A.\u00a0Rubbert-Roth geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}